The Utility of Iron Chelators in the Management of Inflammatory Disorders

The Utility of Iron Chelators in the Management of Inflammatory Disorders

Since iron can contribute to detrimental radical generating processes through the Fenton and Haber-Weiss reactions, it seems to be a reasonable approach to modulate iron-related pathways in inflammation. In the human organism a counterregulatory reduction in iron availability is observed during infl...

Full description

Bibliographic Details
Main Authors:	C. Lehmann, S. Islam, S. Jarosch, J. Zhou, D. Hoskin, A. Greenshields, N. Al-Banna, N. Sharawy, A. Sczcesniak, M. Kelly, K. Wafa, W. Cheliak, B. Holbein
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2015/516740

Similar Items

Comparison of Treatment Effects of Different Iron Chelators in Experimental Models of Sepsis
by: Christian Lehmann, et al.
Published: (2021-01-01)

Iron Chelation in Murine Models of Systemic Inflammation Induced by Gram-Positive and Gram-Negative Toxins
by: Danielle Fokam, et al.
Published: (2020-05-01)

Iron Chelation in Local Infection
by: Cassidy Scott, et al.
Published: (2021-01-01)

Bacterial Resistance in Pneumonia in Developing Countries—A Role for Iron Chelation
by: Sufia Islam, et al.
Published: (2019-04-01)

Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro
by: Maria del Carmen Parquet, et al.
Published: (2018-08-01)

Importance of iron chelation therapy
by: A. Varoğlu
Published: (2011-12-01)

Iron chelating agents for iron overload diseases
by: Guido Crisponi, et al.
Published: (2014-09-01)

Iron Chelation and Multiple Sclerosis
by: Kelsey J. Weigel, et al.
Published: (2014-01-01)

Combination therapies in iron chelation
by: Raffaella Origa
Published: (2014-12-01)

Analysis and formulation of iron chelators
by: Stano, Andrzej Jan
Published: (2006)

Iron overload and chelation therapy in hemoglobinopathies
by: Rayan Bou-Fakhredin, et al.
Published: (2018-04-01)

IRON CHELATION THERAPY IN THALASSEMIA SYNDROMES
by: Paolo Cianciulli
Published: (2009-06-01)

MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
by: Emanuele Angelucci, et al.
Published: (2017-03-01)

Chlorosis in Citrus is Yielding to Iron Chelates
by: Hilgeman, Robert H.
Published: (1956)

Chelating ditertiary phosphine complexes of iron
by: Bellerby, John Murray
Published: (1972)

Iron Chelation Therapy in Myelodysplastic Syndromes
by: Emanuela Messa, et al.
Published: (2010-01-01)

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
by: Kell Douglas B
Published: (2009-01-01)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
by: Naser Mobarra, et al.
Published: (2016-10-01)

Assessment of new iron chelating agents for treatment of iron-overload
by: Sarmento, Carlos V., 1980-
Published: (2007)

Zn/Ga−DFO iron–chelating complex attenuates the inflammatory process in a mouse model of asthma
by: Haim Bibi, et al.
Published: (2014-01-01)

4T1 Murine Mammary Carcinoma Cells Enhance Macrophage-Mediated Innate Inflammatory Responses.
by: Laurence Madera, et al.
Published: (2015-01-01)

Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases
by: George J. Kontoghiorghes, et al.
Published: (2020-06-01)

Synthesis and Study of EDDHA and EDDHMM Iron Chelates
by: CHEN, CHIN-YI, et al.
Published: (2018)

Deferasirox, an oral chelator in the treatment of iron overload
by: I. Portioli
Published: (2013-05-01)

Conformational Stability Effect of Polymeric Iron Chelators
by: Jian Qian, et al.
Published: (2019-11-01)

Potential Treatment of Retinal Diseases with Iron Chelators
by: Wanting Shu, et al.
Published: (2018-10-01)

Controversies on the Consequences of Iron Overload and Chelation in MDS
by: Francesca Vinchi, et al.
Published: (2020-06-01)

Pharmacogenetic study of deferasirox, an iron chelating agent.
by: Ji Won Lee, et al.
Published: (2013-01-01)

Chelators in the Treatment of Iron Accumulation in Parkinson's Disease
by: Ross B. Mounsey, et al.
Published: (2012-01-01)

Iron Chelation Resulting in Renal Phosphate Wasting
by: Lynda Cheddani, et al.
Published: (2018-01-01)

Meta-analysis of the safety of iron chelating agents
by: Li, Niya, et al.
Published: (2015)

Molecular modelling studies on bidentate iron chelators
by: Hadjigeorgiou, Christina
Published: (1998)

Adherence to Iron Chelation Therapy and Its Determinants
by: Sukhmani Sidhu, et al.
Published: (2021-01-01)

Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy
by: Kavita Gaur, et al.
Published: (2018-11-01)

The effect of iron and iron chelators on the growth of an in vitro plasmodium falciparum culture.
by: Jairam, Karuna Thaker
Published: (2018)

Iron Pathways and Iron Chelation Approaches in Viral, Microbial, and Fungal Infections
by: Ravneet Chhabra, et al.
Published: (2020-09-01)

IRON CHELATION THERAPY WITH DEFERASIROX IN THE MANAGEMENT OF IRON OVERLOAD IN PRIMARY MYELOFIBROSIS
by: Elena Maria Elli, et al.
Published: (2014-05-01)

Chelator-Free/Chelator-Mediated Radiolabeling of Colloidally Stabilized Iron Oxide Nanoparticles for Biomedical Imaging
by: Sofia Papadopoulou, et al.
Published: (2021-06-01)

Iron and reactive oxygen in wheat-pathogen interactions
by: Greenshields, David Lewis
Published: (2007)

Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia
by: Murtadha Al-Khabori, et al.
Published: (2013-03-01)